SecBot SecBot
SC 13G/A ·Filed Nov 6, 2026

PCVX

Vaxcyte, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed10d 11h ago SEC0001897612-26-000705
Passive stake amendment
Actionable Insight • Neutral

The increased passive stake signals continued institutional confidence but does not imply activist intent. Monitor for any future conversion to a 13D filing, which would indicate a shift to active engagement.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$63.89
T+0 close · Nov 6, 2026 · via day close
Latest settled
−0.81%
T+5 · $63.37
Vs SPY
−3.41%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $63.89entry
  2. T+1 · 8d ago +5.70%α +3.33% · $67.53
  3. T+5 · 4d ago −0.81%α −3.41% · $63.37
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

T. Rowe Price Investment Management filed an amended Schedule 13G disclosing an 11.6% passive stake in Vaxcyte as of October 31, 2026, up from 9.6% in the prior filing. The increase reflects continued accumulation by a major institutional holder following positive Phase 3 data for VAX-31 and a recent $1.1B capital raise.

Key Financial Metrics

Stake
11.6%
Investor
T. Rowe Price Investment Management, Inc.
Investor Type
mutual fund

Key Facts

  • T. Rowe Price Investment Management disclosed beneficial ownership of 18,136,166 shares of Vaxcyte common stock as of October 31, 2026.
  • The stake represents 11.6% of shares outstanding, up from 9.6% in the prior filing.
  • The filing is a passive investor update under Rule 13d-1(b); the investor certifies shares were not acquired to influence control.
  • T. Rowe Price Capital Appreciation Fund holds 7,430,887 shares (5.2% of class) within the total.

Financial Impact

Stake increased by approximately 2.0 percentage points; no transaction values disclosed.

ownership percentage

Risk Factors

  • As a passive filer, T. Rowe Price could reduce the stake without public notice until the next 13G amendment threshold is crossed.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001897612-26-000705
Document: 0001897612-26-000705-index.html0001897612-26-000705
Document: 0001897612-26-000705.txt0001897612-26-000705

Track record

29 reports on PCVX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +10.87% at T+5 after the Oct 8, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.40 Now $61.61 −1.27% settles Dec 15
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $64.69 Now $61.61 −4.76% settles Dec 11
  3. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Viewing Entry $63.89 Now $61.61 −3.57% settles Dec 7
  4. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $61.61 −3.57% settles Dec 7
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $61.92 Now $61.61 −0.50% settles Dec 4
  6. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $61.92 Now $61.61 −0.50% settles Dec 4
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $61.61 +1.32% settles Dec 2
  8. Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $61.61 +1.32% settles Dec 2
  9. Oct 9, 20265w ago 8-K Bearish 6/10 Entry $70.65 to $67.53 Now $61.61 +12.80% ▲ +4.42% +1.15% vs SPY
  10. Oct 8, 20265w ago 424B5 Bearish 6/10 Entry $71.38 to $63.89 Now $61.61 +13.69% ▲ +10.49% +4.93% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (10h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026